ABOUT
Aims and Scope
About the Journal
Editorial Board
Open Access
Article Processing Charge
BROWSE ARTICLES
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
FOR AUTHORS AND REVIEWERS
Instructions for Authors
Research and Publication Ethics
Checklist
E-submission
Copyright transfer agreement
Search
Close
Original Articles
Endocrine cancer
Phase 1 Study of No-Carrier Added
177
Lu-DOTATATE (SNU-KB-01) in Patients with Somatostatin Receptor–Positive Neuroendocrine Tumors: The First Clinical Trial of Peptide Receptor Radionuclide Therapy in Korea
Hyun Gee Ryoo, Minseok Suh, Keon Wook Kang, Dae-Won Lee, Sae-Won Han, Gi Jeong Cheon
Cancer Res Treat. 2023;55(1):334-343.